The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Value of a Complete or Partial Remission in Severe Lupus Nephritis
Open accessAbstract
BACKGROUND AND OBJECTIVES: The value of a complete remission in severe lupus nephritis is well known but little is known about the impact of a partial remission in this patient population. The purpose of this study was to evaluate the long-term prognosis of achieving a complete or partial remission in a well-defined group of patients with severe lupus nephritis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this study, 86 patients with diffuse lupus glomerulonephritis were reviewed for assessment of the value of a partial remission (50% reduction in baseline proteinuria to < or =1.5 g/d and < or =25% increase in baseline creatinine) and complete remission (proteinuria < or =0.33 g/d and serum creatinine < or =1.4 mg/dl) on outcomes compared with patients who did not attain a remission. These well-characterized patients were entered into a prospective therapeutic trial conducted by the Collaborative Study Group and were followed for more than 10 yr. RESULTS: All biopsies showed diffuse lupus nephritis. A complete remission was attained in 37 (43%) patients, a partial remission in 21 (24%) patients, and no remission in 28 (32%) patients. Baseline clinical and serologic features were similar among the groups, but patients with a complete remission had a lower serum creatinine and chronicity index compared with patients with partial or no remission. The patient survival at 10 yr was 95% for complete remission, 76% for partial remission, and 46% for no remission. The renal survival at 10 yr was 94% for complete remission, 45% for partial remission, and 19% for no remission, and the patient survival without end-stage renal disease at 10 yr was 92% for complete remission, 43% for partial remission, and 13% for no remission. CONCLUSION: Even a partial remission in lupus nephritis is associated with a significantly better patient and renal survival compared with no remission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
Weening, J. J., D’Agati, V. D., Schwartz, M. M., Seshan, S. V., Alpers, C. E., Appel, G. B., Balow, J. E., Bruijn, J. A., Cook, T., Ferrario, F., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000108969.21691.5d · Cited by 2,008
Self-citationMycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
Ginzler, E. M., Dooley, M. A., Aranow, C., Kim, M. Y., Buyon, J., Merrill, J. T., Petri, M., Gilkeson, G. S., Wallace, D. J., Weisman, M. H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043731 · Cited by 1,128
Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis
Chan, T. M., Li, F. K., Tang, C. S. O., Wong, R. W. S., Fang, G. X., Ji, Y. L., Lau, C. S., Wong, A. K. M., Tong, M. K. L., Chan, K. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431604 · Cited by 954
Prognostic factors in lupus nephritis
Austin, H. A., Muenz, L. R., Joyce, K. M., Antonovych, T. T., Kullick, M. E., Klippel, J. H., Decker, J. L., & Balow, J. E. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90338-8 · Cited by 773
Renal Disease. Classification and Atlas of Glomerular Diseases.
(1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-5-801_2 · Cited by 672
Gourley, M. F., Austin III, H. A., Scott, D., Yarboro, C. H., Vaughan, E. M., Muir, J., Boumpas, D. T., Klippel, J. H., Balow, J. E., & Steinberg, A. D. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00003 · Cited by 607
Chan, T.-M., Tse, K.-C., Tang, C. S.-O., Mok, M.-Y., & Li, F.-K. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080686 · Cited by 479
A Controlled Trial of Plasmapheresis Therapy in Severe Lupus Nephritis
Lewis, E. J., Hunsicker, L. G., Lan, S.-P., Rohde, R. D., & Lachin, J. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205213262101 · Cited by 473
Self-citationHoussiau, F. A., Vasconcelos, C., D'Cruz, D., Sebastiani, G. D., de Ramon Garrido, E., Danieli, M. G., Abramovicz, D., Blockmans, D., Mathieu, A., Direskeneli, H., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20666 · Cited by 391
Factors predictive of outcome in severe lupus nephritis
Korbet, S. M., Lewis, E. J., Schwartz, M. M., Reichlin, M., Evans, J., & Rohde, R. D. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70262-9 · Cited by 374
Self-citationIllei, G. G., Takada, K., Parkin, D., Austin, H. A., Crane, M., Yarboro, C. H., Vaughan, E. M., Kuroiwa, T., Danning, C. L., Pando, J., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10142 · Cited by 329
Focal and Segmental Glomerulosclerosis: Definition and Relevance of a Partial Remission
Troyanov, S., Wall, C. A., Miller, J. A., Scholey, J. W., & Cattran, D. C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070593 · Cited by 282
Long-term follow-up of patients with lupus nephritis
Appel, G. B., Cohen, D. J., Pirani, C. L., Meltzer, J. I., & Estes, D. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90645-0 · Cited by 278
“Nephritic flares” are predictors of bad long-term renal outcome in lupus nephritis
Moroni, G., Quaglini, S., Maccario, M., Banfi, G., & Ponticelli, C. (1996) · Kidney International · doi:10.1038/ki.1996.528 · Cited by 267
Idiopathic membranous nephropathy: Definition and relevance of a partial remission
Troyanov, S., Wall, C. A., Scholey, J. W., Miller, J. A., & Cattran, D. C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00873.x · Cited by 257
Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide
Ioannidis, J. P. A., Boki, K. A., Katsorida, M. E., Drosos, A. A., Skopouli, F. N., Boletis, J. N., & Moutsopoulos, H. M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00832.x · Cited by 231
Harley, J. B., Sestak, A. L., Willis, L. G., Fu, S. M., Hansen, J. A., & Reichlin, M. (1989) · Arthritis & Rheumatology · doi:10.1002/j.2326-5205.1989.tb00013.x · Cited by 188
Long-term Outcome of Diffuse Proliferative Lupus Glomerulonephritis Treated with Cyclophosphamide
Mok, C. C., Ying, K. Y., Ng, W. L., Lee, K. W., To, C. H., Lau, C. S., Wong, R. W. S., & Au, T. C. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.08.045 · Cited by 163
Clinical presentation and monitoring of lupus nephritis
Balow, J. E. (2005) · Lupus · doi:10.1191/0961203305lu2055oa · Cited by 124
Outcome criteria for lupus nephritis trials: A critical overview
Boumpas, D. T., & Balow, J. E. (1998) · Lupus · doi:10.1191/096120398678920758 · Cited by 94
Cortés-Hernández, J., Ordi‐Ros, J., Labrador‐Horrillo, M., Segarra-Medrano, A., Tovar, J. L., Balada, E., & Vilardell, M. (2003) · Lupus · doi:10.1191/0961203303lu340oa · Cited by 83
Sustained remission of lupus nephritis
Barber, C. E. H., Geldenhuys, L., & Hanly, J. G. (2006) · Lupus · doi:10.1191/0961203306lu2271oa · Cited by 53
Response to treatment as a predictor of longterm outcome in patients with lupus nephritis.
Fraenkel, L., MacKenzie, T. A., Joseph, L., et al. (1994) · PubMed · Cited by 53
Identification of antinative DNA antibodies in cryoglobulinemic states
Roberts, J. L., & Lewis, E. J. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90770-2 · Cited by 44
Self-citationMosca, M., Neri, R., Giannessi, S., et al. (2001) · Lupus · doi:10.1191/096120301680416931 · Cited by 28
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Bertsias, G. K., Tektonidou, M., Amoura, Z., Aringer, M., Bajema, I., Berden, J. H. M., Boletis, J., Cervera, R., Dörner, T., Doria, A., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201940 · Cited by 1,007
Anders, H.-J., Saxena, R., Zhao, M.-H., Parodis, I., Salmon, J. E., & Mohan, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0141-9 · Cited by 958
Almaani, S., Meara, A., & Rovin, B. H. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05780616 · Cited by 930
Rovin, B. H., Teng, Y. K. O., Ginzler, E. M., Arriens, C., Caster, D. J., Romero-Diaz, J., Gibson, K., Kaplan, J., Lisk, L., Navarra, S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00578-x · Cited by 635
Metadata
- Authors
- Chen, Y. E., Korbet, S. M., Katz, R. S., Schwartz, M. M., & Lewis, E. J.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2008-01
- Volume
- 3
- Issue
- 1
- Pages
- 46-53
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2134338422
- Cited by
- 312
- References
- 27
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.